FIELD: medicine.
SUBSTANCE: offered is application of a composition substantially consisting of trans-clomiphene or its pharmaceutically acceptable salt for preparing a drug to be introduced in a male patient in a single dose every 3-30 days for treating hypogonadism, lipodystrophy, benign prostatic hypertrophy or prostate cancer (versions). One of side effect of exogenous testosterone, namely decreased biosynthesis level of follicle-stimulating hormone causing reduced sperm formation is compensated. Contrariwise, the product is applied in treating a disorder associated with male hypogonadism and related disturbances, including reduced muscle bulk, body physical capacity limitation, decreased bone density, decreased libido, decreased potency, reduced benign prostatic hyperplasia and infertility.
EFFECT: product increases persistently total testosterone level to a normal range with no abnormal high peaks.
18 cl, 7 dwg, 3 ex
